Journal Guide

Clinical Colorectal Cancer is a peer-reviewed, quarterly journal that publishes original articles describing various aspects of clinical and translational research of gastrointestinal cancers. Clinical Colorectal Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of colorectal, pancreatic, liver, and other gastrointestinal cancers. The main emphasisis on recent scientific developments in all areas related to gastrointestinal cancers. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, andprognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms, as well as reports on defects of epigenetic regulation, in relation to human disease, diagnosis and therapy. Epigenetic research in disease model organisms is particularly welcome.Topics of interest include, but are not limited to:  Clinical epigenetic research Chromatin modification/Histone modification Epigenetics and disease  Epigenetics and aging Epigenetics in developmental processes Epigenomics and pharmacoepigenomics Non-coding RNA and gene silencing Epigenetics, environment, nutrition and evolution

Clinical Epigenetics studies epigenetic changes in normal and diseased cells in response to internal or external factors with the aim to translate basic epigenetic research into diagnosis, therapy and prevention.

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/725537/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical Oncology is essential reading for all those with an active interest in the treatment of cancer. Its multidisciplinary approach allows readers to keep up-to-date with developments in their own as well as related fields.Each issue is carefully selected to provide a combination of high quality original research, informative editorials and state-of-the-art reviews. The Journal covers all aspects of the clinical management of cancer patients and its authors are drawn from leading international centres.The Journal features papers on all types of malignant disease including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical Sarcoma Research publishes articles related to research on sarcomas, both of soft tissue and bone.

Clinical and Translational Medicine (CTM) is a peer-review open access journal published under the brand SpringerOpen and aims to play an important and recognized role in reporting knowledge that contributes towards the understanding of molecular mechanisms of disease. CTM also aims to foster a predictive, preventive, personalized and practical approach towards precision medicine, leading to improved patient prognosis. The journal provides a forum for exchange of ideas between basic and clinical scientists on molecular and cellular mechanisms of disease and potential therapies.Clinical and Translational Medicine is a truly international, peer-reviewed, and open access journal devoted to the publication of articles on scientific and clinical investigations which will promote and accelerate the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. CTM emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. CTM will specially focus on the bench to bedside approach, favouring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine. CTM welcomes submissions from companies, clinicians, scientists and policy makers. 

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of biomarkers for cancer diagnosis, prognosis or prediction of treatment response, identification of new targets for cancer therapy, as well as development of new technologies for research and treatment of cancer are the major themes covered by both the educational series and research articles. A broad spectrum of subjects, including the molecular and cellular bases of di

Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists and radiologists.Journal published under the patronage of Stowarzyszenia na Rzecz Walki z Rakiem „Geny Zycia” (Poznan) and Fundacji Onkologii Doswiadczalnej i Klinicznej (Warsaw).

Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.

This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of breast cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention, systemic therapy, and translational research. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided. 

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of colorectal cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention and early detection, current and emerging therapeutic approaches, and molecular epidemiology. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.